Enthesitis

2

Review clinical trials related to Enthesitis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons

Tendon pathologies (enthesitis) are a characteristic component of psoriatic arthritis (PsA), and are observed in 35% to 50% of PsA patients. The Achilles tendon is one of the most commonly affected sites. This condition often causes great morbidity and loss of quality of life, and response only suboptimal to current intervention strategies. One of the main obstacles for the development of effective treatment methods is that the disease mechanisms remain poorly understood. To our knowledge, no one has yet ascertained the presence and function of immune-competent cells and inflammatory markers in tendons tissue from PsA patients suffering from Achilles enthesitis.

Participants needed: 30
Trial details
Age: 18-70Biological sex: AllType: ObservationalSponsor: Odense University HospitalUpdated: Dec 5, 2025Locations: 2
Eligibility criteria

Fulfilling the CASPAR criteria [+2]

Other inflammatory rheumatic diseases than PsA [+2]

Status: Recruiting

A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)

It is an observational, single-center, prospective, exploratory, open-label study to assess the efficacy and safety of IL-17 inhibitors on subclinical enthesitis in patients with moderate to severe psoriasis with subclinical enthesitis based on Power Doppler (PD) Ultrasonography (PDUS)

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolUpdated: May 23, 2025Locations: 2
Eligibility criteria

Adult patients ( ≥ 18 years of age) with chronic plaque-type psoriasis [+4]

Diagnosis of PsA2 according to CASPAR [+15]